| INTRODUCTION
Sleep apnea can be categorized as either obstructive (i.e., caused by upper airway collapse) or central (i.e., caused by brain dysfunction in sending signals to the muscles that control breathing) (Somers et al., 2008) . Cheyne-Stokes respiration (CSR) and periodic breathing (PB) are types of central sleep apnea (CSA) caused by brain dysfunction that impairs signals sent to the muscles that control breathing. In contrast to CSR and PB, obstructive sleep apnea is caused by a mechanical collapse or obstruction of the airway (Somers et al., 2008) . Mechanisms that interplay in maintaining an adequate balance of carbon dioxide and oxygen in the blood and that may contribute to the development of CSA, CSR and PB include increased chemoreceptor sensitivity to fluctuating carbon dioxide and oxygen blood levels, circulatory delay and baseline oxygen and carbon dioxide levels (Leung et al., 2012) .
Sleep apnea has been associated with increased sympathetic nervous activity, heart rate, blood pressure, number of arrhythmias and poor outcomes in cardiac populations (Linz et al., 2015) . CSR and PB have been associated with an increased risk for mortality in patients with heart failure (Brack et al., 2007; Hanly & Zuberi Khokhar, 1996; La Rovere et al., 2007; Lanfranchi et al., 1999) . In prior studies CSR and PB were measured using the gold standard polysomnography (Hanly & Zuberi Khokhar, 1996; La Rovere et al., 2007) , unattended sleep study (Lanfranchi et al., 1999) , or portable systems (Brack et al., 2007; La Rovere et al., 2007) , which are costly, and obtrusive.
Alternative noninvasive methods for identifying CSR and PB using continuous ECG waveform data have expanded in the past 20 years.
The use of ECG waveforms to derive respiratory rate was first investigated by Moody et al. (1986) who used a two lead ECG arrhythmia detector and a pneumatic respiration transducer in patients during a sleep lab study to describe how changes in the cardiac electrical axis during respiration could be used to derive respiration and detect apnea. Moody et al. (1985) , later used Holter monitors to derive ECG respiration and identify sleep apnea in patients referred to the sleep lab for sleep apnea and CSR in heart failure patients; and later described ECG algorithms to derive sleep apnea (Penzel et al., 2002) .
Research has expanded in the past few years to include study of derivation of respiratory rate, tidal volume and apnea. A review by Helfenbein et al. (2014) , described how changes in QRS amplitude, heart rate variability and electromyogram activity are three different techniques that utilize ECG data to derive respiratory rate. Recently, Weiss et al. (2014) , used an algorithm that selected the best leads to derive respiratory rate from either intracardiac or body surface ECG in intubated and mechanically ventilated swine; furthermore, modulation in the ECG derived respiratory rate was used by the same group to derive tidal volume . Alternatively, ECG data routinely collected during polysomnography has been used to derive apnea and hypopnea (Pichot et al., 2015; Stein et al., 2003; Varon et al., 2015) ; using cyclic variations of the heart rate (Stein et al., 2003) , or changes in the QRS complex (Pichot et al., 2015; Varon et al., 2015) , and with an accuracy to detect the events of 84%, 89% and 85% respectively (Pichot et al., 2015; Stein et al., 2003; Varon et al., 2015) .
An ECG based method to derive CSR and PB in a healthy and a cardiac heart failure group using 12-lead Holter monitor data was published by Haigney et al. (2014) . In a further assessment of this noninvasive ECG method we designed a study to examine the following research aims: (1) to compare ECG-derived CSR and PB between a group of healthy ambulatory community based participants to a group of patients presenting to the emergency department with symptoms suggestive of acute coronary syndrome (ACS); and (2) to compare the rate of CSR and PB in hospitalized patients specifically between those with a cardiac non-ACS discharge diagnosis to those with an ACS discharge diagnosis.
We purposely chose and prospectively enrolled healthy individuals to determine the ability of the ECG to discriminate CSR and PB between a healthy group and a hospitalized group. We hypothesized the healthy group would have fewer CSR and PB episodes than the group of patients seeking emergency care for symptoms of ACS.
| METHODS

| Study design
Data from two studies were used. The data for the healthy control group came from a prospective descriptive study entitled Quantifying (Schindler et al., 2007) . The Institutional Review Board at the university approved both studies and research nurses obtained informed consent from all participants.
| Study setting and population
| Healthy group
The healthy control group included a convenience sample of 100 participants 18 years of age and older who were recruited between January and March, 2013. Potential participants were carefully queried about medical history to ensure they met the criteria for "healthy." Exclusion criteria included skin allergy to electrode adhesive, current flu symptoms, or any of the following: coronary heart disease, angina pectoris, myocardial infarction, coronary bypass surgery, prior percutaneous coronary intervention (angioplasty, or stent), heart failure, heart transplantation, hypertension requiring medication, atrial fibrillation, pacemaker, implantable cardioverter defibrillator, ablation therapy, stroke, diabetes mellitus, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, restrictive lung disease, asthma requiring year-round inhaler, sleep apnea and/or treatment for sleep apnea with continuous positive airway pressure, cancer treatment in the past 12 months, end-stage renal failure or renal dialysis. In addition, participants were excluded if they were taking medications routinely for the above stated diseases. Finally, potential participants were also screened for sleep apnea with the Geisinger Health Tool and excluded if they answered "yes" to two or more of the questions from this tool (Chung et al., 2008) .
Healthy participants wore an H12 + Holter recorder (Mortara Instrument Inc, Milwaukee, WI, USA) for 24 hr, during which they were instructed to maintain routine daily activities. The H12 + Holter acquires all 12 ECG leads simultaneously using a digital sampling rate of 1,000 samples per second. Electrodes were placed by the primary investigator (AT) using a Mason-Likar electrode configuration (Mason & Likar, 1966) . Each electrode site was marked with ink and the participants were instructed on how to replace electrodes and lead wires (i.e., after showering or if electrodes came off).
| Hospitalized group
The IMMEDIATE AIM study has been described in detail previously (Schindler et al., 2007) . Briefly, patients presenting to the emergency department with symptoms suggestive of ACS from April 2002 to December 2004 were prospectively enrolled. Research nurses obtained verbal assent followed by written informed consent from 1,308 patients. This consent method was used so that the 12-lead Holter recording (Mason-Likar electrode configuration) could be applied as soon as possible following presentation to the emergency department. The median door-to-Holter initiation was 44 min (Schindler et al., 2007) . Although the primary study enrolled 1,308 patients using a 12-lead Holter recorder, only a subset of 188 (14%) patients enrolled at the end of the study were monitored with a H12 + device (Mortara Instrument Inc.), which records ECG at 1,000 samples per second, a requirement for deriving CSR and PB from the ECG. Of the 188 patients, 50 (26.6%) were excluded because a cardiac diagnosis was ultimately ruled out, 40 (21.3%) were excluded because they had <18 hr of ECG recording, and 8 (4.0%) were excluded because of an arrhythmia or waveform pattern that confounds the measurement of CSR and PB (i.e., atrial fibrillation, atrial flutter, or ventricular paced rhythm). Thus, the final sample included for the current analysis was 90 patients.
The final diagnosis in the 90 patients was cardiac non-ACS (i.e., valvular heart disease, congestive heart failure, pericarditis, new onset arrhythmia, stable angina, hypertension crisis, aortic dissection or an- 
| ECG analysis
The 12-lead ECG Holter data was downloaded and analyzed with HScribe software (4.34 software; Mortara Instrument Inc.). The high fidelity ECG data were then processed with research software (Super ECG; Mortara Instrument Inc.) to identify CSR and PB episodes during the recording period for each participant.
| SuperECG software
The details of how SuperECG software identifies CSR and PB have been published previously by Haigney et al. (2014) . Briefly, tidal volume increases during inspiration cause the heart to shift in the thorax which then leads to morphology changes to the QRS waveform.
SuperECG software uses beat to beat changes in QRS morphology to derive tidal volume and calculate CSR and PB episodes from Holter ECG recordings. The software first calculates the QRS amplitude mean square variation over 15 s (area divided by width in 1/4 μV units); and then derives a waveform from the mean QRS amplitude (sample rate of 1 sample per second). The derived waveform is used to measure changes in tidal volume and calculate CSR and PB. Examples of SuperECG software technology to detect breathing are displayed in Figure 1 . CSR is identified by the software when three or more consecutive cycles of hyperpnea/hypopnea/apnea respiration with a crescendo-decrescendo breathing pattern occur (Figure 1, top) . PB is identified by the software when three or more consecutive cycles of hyperpnea/hypopnea respiration with a crescendo-decrescendo breathing pattern occur without apnea (Figure 1, bottom) . Hence, the distinguishing feature of CSR and PB is that CSR has a period of apnea whereas PB does not.
| Statistical analysis
Continuous data are reported as mean ± SD. The variables monitoring time, age and body mass index (BMI) were not normally distributed and the Wilcoxon rank-sum test was used to compare group mean ranks for these variables. The Pearson chi-square test was used to compare group frequencies for the categorical variables gender and ethnicity. The chi-square test followed by post hoc pairwise comparisons was used for the variable race and the Fisher's exact test was used when the assumptions for Pearson chisquare test were not met. Spearman rank order correlations were used to test for a correlation between demographic variables (age and BMI) and the variables of interest, CSR and PB. Because CSR and PB data had the following characteristics; positive integer count variables, truncated at zero, skewed to the right and over-dispersed, the incidence rate ratio between the two groups for each analysis was calculated using negative binomial regression (Hutchinson & Holtman, 2005) . Estimation was carried out using a nonparametric, bias-corrected bootstrap with 5,000 repetitions to reduce the potential influence of several cases with extreme outliers for both outcomes (CSR and PB) and bias corrected confidence intervals are reported (Erceg-Hurn & Mirosevich, 2008; Wood, 2005; Zhu, 1997) . Statistical analyses were conducted using Stata Release 14 (StataCorp, College Station, TX, USA). A p value <.05 was considered statistically significant.
| RESULTS
| Comparison of CSR and PB between healthy participants and hospitalized patients
As shown in Table 1 , the mean age of healthy group was younger (34 years vs. 67 years; p < .001), and were predominantly white (70% vs. 41%; p < .001) as compared to the hospitalized group. As a group, the healthy individuals had a lower BMI (25 vs. 28; p < .001) than the hospitalized group.
Mean age was not only significantly different between the healthy and the hospitalized groups but age also correlated with both CSR (r s = +.29 , p < .001) and PB (r s = +.36, p < .001). BMI was significantly different between the two groups and BMI was also a confounder; thus, both age and BMI were controlled for in all subsequent analyses.
CSR and PB counts were adjusted in the negative binomial regression model to account for differences in the number of hours of monitoring for which data were collected for each patient (ranging between 18 and 24 hr).
The mean CSR count and daily PB counts were different between the healthy and hospitalized groups (1 vs. 9, p < .001) and (9 vs. 24, p < .001) ( Table 2) respectively. Furthermore, regression analyses indicated hospitalized patients had 7.3 times more CSR (95% CI = 2.00-28.96 bias corrected) and 1.64 times more PB (95% CI = 1.15-2.38 T A B L E 1 Baseline characteristics comparing healthy group to hospitalized patients bias corrected) than healthy individuals after controlling for age and BMI.
| Comparison of CSR and PB between hospitalized patients with cardiac non-ACS versus ACS
The hospitalized group (n = 90) was further subdivided to determine whether patients who had a final diagnosis of cardiac non-ACS diagnosis (n = 51) differed from those diagnosed with an ACS diagnosis The cardiac non-ACS group had a lower daily mean CSR count (3 vs. 17, p < .001) and a lower daily mean PB count (22 vs. 27, p < .001) than the ACS group (Table 3 ). Regression also showed that patients with a positive ACS diagnosis had 6.01 more CSR (CI = 2.78-13.73 bias corrected) than those with cardiac non-ACS diagnosis.
| DISCUSSION
This is the first study to investigate the use of ECG-derived CSR and PB measurements in a group of patients in a hospital setting. Our study is unique in that we compared a healthy group, unlikely to have CSR or PB, to a group of hospitalized patients admitted for suspected ACS.
Our findings indicate that ECG-derived CSR rates are more than seven times higher in hospitalized cardiac patients compared with healthy individuals. Moreover, when comparing the subgroup of hospitalized patients by discharge diagnosis (non cardiac ACS vs. confirmed ACS), patients with ACS had the highest rate of CSR (average, 17.3 episodes per 24-hr period.
Using ECG-derived measurements, Haigney et al. (2014) , reported an average of 2.6 CSR episodes per 24-hr period in healthy subjects. We also observed a low number of CSR episodes (average, 1.04 per 24-hr period) in our healthy subjects. In an extension of the Haigney et al. (2014) , study, we found healthy subjects experienced PB (average, 9.24 per 24-hr period). These findings support the knowledge that irregular breathing patterns such as PB exist naturally even in healthy individuals, which is believed to maintain T A B L E 3 Cheyne-Stokes respiration and periodic breathing comparing hospitalized patients with acute coronary syndrome to hospitalized patients with a cardiac non acute coronary syndrome diagnosis physiologic stability (Dunai, Kleiman, & Trinder, 1999; Eckert et al., 2007) . Haigney et al. (2014) also found patients with heart failure to have an average of 19 CSR episodes over a 24-hr period which is congruent with our results in the ACS group but not our cardiac non-ACS group (24-hr CSR episode average of 17 and 3 respectively).
Researchers have used the gold standard polysomnography to measure sleep disordered breathing, CSA and obstructive sleep apnea in patients who have heart failure during sleep (Javaheri et al., 1998; Sharma, Owens, & Malhotra, 2010; Sin et al., 1999) . Javaheri et al.
(1998) reported a 51% CSA prevalence, and Sin et al. (1999) reported 32.9% CSA prevalence and 37.3% obstructive sleep apnea prevalence.
Yet, few studies have evaluated CSA or obstructive sleep apnea in patients with ACS. Prior studies evaluated obstructive sleep apnea and reported rates of: 43.1%, 76%, 47%, and 63% respectively, (Areias et al., 2012; Correia et al., 2012; De Jesus et al., 2010; Leão et al., 2016 ) when using either the Berlin Questionnaire (Correia et al., 2012; De Jesus et al., 2010) or portable systems (Areias et al., 2012; Leão et al., 2016 
| Limitations
This study included a small sample consisting of 100 healthy participants and 90 hospitalized patients. A thorough interview was conducted to assess participants' health status, however, inclusion in the healthy group was determined by patients' self-report. Patients in the hospitalized group were enrolled from a single emergency room.
While target monitoring time was 24 hr, missing data led to the inclusion of cases that had at least 18 hr of continuous ECG recording.
Variables of interest, CSR and PB, were not measured with the gold standard, polysomnography.
| CONCLUSION
Continuous 12-lead ECG data appears to identify CSR and PB patterns in hospitalized cardiac patients. CSR and PB counts were significantly different between healthy and hospitalized patients and also between patients with and without an ACS diagnosis. Hospitalized patients, especially those with an ACS discharge diagnosis had more CSR and PB than healthy individuals and cardiac non-ACS patients.
The Canadian Continuous Positive Airway Pressure for Patients with
Central Sleep Apnea and Heart Failure (CANPAP) study reported that treating heart failure and CSA patients with continuous positive airway pressure did not decrease patient morbidity or mortality. However, testing and treating CSA might help clinicians screen for ACS before heart failure results.
Further research is needed to determine whether these ECGderived respiratory parameters change before and after ACS ensues, are linked to adverse patient outcomes and whether continuous measurement would be valuable in clinical practice to identify patients with sleep disordered breathing.
